all adult patients (18 - 60 years of age) with an acute cerebrovascular event of any etiology

Fabry diagnostic will be done centrally: blood samples will be stored for analysis of a-galactosidase in blood, Gb3 as well as lyso-Gb3. In all cases direct analysis of the gene will be done, especially in females where due to the Lyonisation effect a-galactosidase activity might be normal in blood although the patient might suffer from Fabry disease.

Cerebrovascular Accident

Stroke, Acute

Cerebral Stroke

Department of Neurology, Kreiskrankenhaus Altenburg

Dept. of Neurology, Vivantes Netzwerk für Gesundheit GmbH, Klinikum Neukölln

Department of Neurology, Allgemeines Krankenhaus Celle

Department of Neurology, Klinikum Chemnitz gGmbH

Heinrich-Heine University Duesseldorf, Dept. of Neurology

Universitätsklinikum Giessen, Department of Neurology

Department of Neurology S10, Universitaetsklinikum Hamburg-Eppendorf

Universität Heidelberg, Klinik für Neurologie

Department of Neurology, Universitaetsklinikum Jena

Dept. of Neurology, Ökumenisches Hainich Klinikum gGmbH

Universitätsklinikum Regensburg, Klinik für Neurologie

University of Rostock, Department of Neurology

University of Ulm, Department of Neurology

Institute of Psychiatry and Neurology, Dept. of Neurology

Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease

FASEP Fabry and Stroke Epidemiological Protocol RISK FACTORS IN ISCHEMIC STROKE PATIENTS WITH FABRY DISEASE AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGICAL PROTOCOL

Prof. Dr. Arndt Rolfs

Prof. Dr. med.

University of Rostock

all adult patients (18 - 55 years of age) with an acute cerebrovascular event of any etiology

Fabry diagnostic will be done centrally: blood samples will be retained for analysis of a-galactosidase in blood to diagnose an a-galactosidase deficit; in females direct analysis of the gene has to be done since due to the Lyonisation effect a-galactosidase activity might be normal in blood although the patient might suffer from Fabry disease.

Observational study, only laboratory analysis and diagnostic interventions done; no drug tested

No intervention

Universitätsklinikum für Neurologie

Department of Neurology, Universitaetsklinik fuer Neurologie Innsbruck

Wagner-Jauregg Linz, Department of Neurology

Christian-Doppler-Klinik, Department für medizin. Studien

Krankenhaus der Barmherzigen Brüder, Abteilung für Neurologie

Middelheim General Hospital, Dept. of Neurology/Memory Clinic

UZ Gasthuisburg Hospital

Department of Neurology, University Hospital Sestre Milosrdnice

Helsinki University Central Hospital, Department of Neurology

Hopital Neurologique de Lyon, Service d'urgences Neurovasculaires

Department of Neurology, S. Khechinashvili University clinic of Tbilisi state medical university

Department of Neurology, Klinikum Hohe Warte

Charite Campus Benjamin Franklin, Dept. of Neurology

Klinikum Bremen Mitte gGmbH, Neurologische Klinik

Department of Neurology, Universitaetsklinikum Carl Gustav Carus

Dept. of Neurology, Johann-Wolfgang-Goethe-Universität

University of Giessen-Marburg Dept. of Neurology

Department of Neurology, Ernst-Moritz-Arndt-University

Dept. of Neurology, Martin-Luther-Universität, Universitätsklinik und Poliklinik für Neurologie

University of Heidelberg, Department of Neurology

University Schleswig-Holstein, Dept. of Neurology

Department of Neurology, Universitaetsklinikum Leipzig

Department of Neurology, Universitaetsklinikum Giessen und Marburg GmbH

University of Muenster, Dept. of Neurology

Ludwig-Maximilians-University of Munich, Dept. of Neurology

Department of Neurology, Klinik und Poliklinik fuer Neurologie

Department of Neurology, University Tuebingen

The Adelaide and Meath Hospital, Department of Neurology

Dept. of Neurology, Ospoedale Maggiore Policlinico

Neuromedical Ward, Mater Dei Hospital

Centro Hospitalar de Lisboa Central, Servico de Neurologia

Department of Neurology, Hospital Universitario La Paz

Stroke Prevention Research Unit, Dept. of Clinical Neurology, University of Glasgow, Southern General Hospital

Stroke Prevention Research Unit, John Radcliffe Hospital

Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients

Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in an Unselected Group of Young Stroke Patients: an International, Multicentre Prevalence Study

fabry disease/obesitas

Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease

Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients

De meest complete database met geneeskrachtige kruiden, ondersteund door de wetenschap